Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea
Johannes Niesmann, J.Q. Del Rosso, Jens Rossbacher, Cheryl Burgess et al.
Citations
5 citations
Journal
JAMA Dermatology
Topics
Acne and Rosacea Treatments and Effects
Field-Weighted Citation Impact (FWCI)
10.02
article
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea
Johannes Niesmann, J.Q. Del Rosso, Jens Rossbacher, Cheryl Burgess, Jorge Santander, Mark Amster, Hector Wiltz, Cheryl Hull, Faraz Badar, Javier Alonso‐Llamazares, Scott Guenthner, Thomas Dirschka, Oliver Weirich, Cindy E. Owen, Diana Vargas, Edward Lain, Michael H. Gold, Mark S. Lee, Douglas Logan, Zoé Kececioglu Draelos, David L. Fried, Tanja Fischer, Linda Stein Gold, Beate Schwarz, Steven A. Davis, Beatrice Gerlach, Paul S. Yamauchi, Oscar De Valle, Mark A. McCune, Sureka Bollepalli, R. Dominicus, Francisco A. Kerdel, David Fivenson, Walter K. Nahm, Megan Brinkworth Vissing, Luís M. Allende, S. Ekanayake‐Bohlig, Rosalyn Elizabeth George, Edward Lain, Srinivas Sidgiddi, Udo Amann, Sebastian Zimmer, Jeffrey Adelglass, Melody Lynn Stone, Steven Grekin, Sunil Dhawan, Jane Chang, Janet DuBois, Theresa Greene Knoepp, Francisco Flores, Matthew L. Miller, Athanasios Tsianakas, Robert S. Haber, Megan Couvillion, Neal Bhatia, Terry M. Jones, J. DeMaria, Kenneth Dawes, Stephen M. Schleicher, H. Brüning, Steven Kempers, Eddie Armas, Pinkas E. Lebovits
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA DermatologyVol. 161(5)
Institutions
Henry Ford Health System (US), Dermatology Consulting Services (US), Therapeutics Clinical Research (US), Texas Retina Associates (United States) (US)